Charge syndrome is a rare genetic condition that affects multiple parts of the body. People with CHARGE syndrome often have vision or hearing differences, feeding and breathing difficulties, and heart or kidney defects. Features usually start before birth and continue lifelong, but severity can vary. Care often includes surgeries, hearing or vision support, therapies, and coordinated specialist care. Many living with CHARGE syndrome do well with early intervention, though some serious complications can affect survival in infancy.
Overview
Charge syndromeSymptoms
CHARGE syndrome features usually show at birth or soon after. Signs can include eye differences, blocked nasal passages, heart defects, feeding or breathing trouble, hearing loss with ear and balance issues, poor growth, genital differences, and developmental delays.
Outlook and prognosis
Many living with CHARGE syndrome grow and learn with tailored support, though medical needs are often complex early on. Hearing, vision, heart, airway, and feeding challenges can improve with surgeries, therapies, and assistive devices. Lifespan varies, but specialized, coordinated care improves outcomes and independence.
Causes and risk factors
CHARGE syndrome usually results from a new CHD7 gene mutation; less often, it’s inherited in an autosomal dominant way from an affected parent. No proven environmental or lifestyle risks; recurrence is generally low but can be higher with parental mosaicism.
Genetic influences
Genetics play a central role in CHARGE syndrome. Most cases are caused by changes in the CHD7 gene, usually new (not inherited) variants; a minority are inherited in an autosomal dominant pattern. Genetic testing confirms diagnosis and supports family planning.
Diagnosis
CHARGE syndrome is usually diagnosed by recognizing a pattern of clinical features, then confirming with genetic testing. Imaging and hearing or vision assessments often support the genetic diagnosis of CHARGE syndrome.
Treatment and drugs
Treatment for CHARGE syndrome is tailored to each person’s needs and age. Teams may coordinate breathing or feeding support, heart or ear surgeries, vision and hearing aids, hormone therapy, and therapies for speech, balance, and learning. Regular follow‑up guides adjustments over time.
Symptoms
From the first days of life, many families notice challenges with feeding, breathing through the nose, or soothing a baby who startles easily to sound or light. Vision and hearing differences, heart issues, and slow growth are also common in CHARGE syndrome. Features vary from person to person and can change over time. In newborns, early features of CHARGE syndrome can include breathing or feeding troubles, problems seeing or hearing, and slow growth.
Some children are born with a gap in parts of the eye that affects vision. In medical terms, this is coloboma; in everyday life, it shows up as light sensitivity or blind spots. Regular eye checks help protect sight.
Heart differences can range from small holes to changes in how blood leaves the heart. Many babies with CHARGE syndrome need an early heart scan, and some need surgery. Ongoing follow‑up helps track heart health.
Blocked passages at the back of the nose can make nose‑breathing hard, especially during feeds. Clinicians call this choanal atresia, which means the nasal passage is narrowed or closed. Mouth‑breathing or hospital care after birth may be needed.
Weak suck, trouble coordinating swallow and breathing, and reflux are common in CHARGE syndrome. Some babies need thickened feeds, a feeding tube, or swallow therapy to eat safely. Care plans often change as feeding skills improve.
How people usually first notice Charge syndrome?
Many parents first notice CHARGE syndrome shortly after birth when a baby has trouble feeding or breathing, or when an eye difference like a small or missing iris opening (coloboma) is seen during the first exam. Doctors may also pick up the first signs of CHARGE syndrome on newborn checks because of blocked or narrow nasal passages, distinctive ear shape, or heart defects heard as a murmur and confirmed by imaging. In some cases, clues appear in pregnancy—such as growth concerns or heart findings on ultrasound—prompting genetic evaluation and explaining how CHARGE syndrome is first noticed.
Types of Charge syndrome
CHARGE syndrome varies a lot from person to person, and doctors recognize a few clinical variants based on how many hallmark features are present and how strongly they show up. Symptoms don’t always look the same for everyone. Broadly, clinicians describe types of CHARGE syndrome by diagnostic certainty rather than separate genetic forms, since most confirmed cases share changes in the CHD7 gene. Understanding the main types of CHARGE presentations can help you make sense of the different types of CHARGE syndrome discussed in clinics and research.
Definite CHARGE
All or most hallmark features are present based on a standard scoring system. People often have several of the core signs, such as coloboma, choanal atresia, characteristic ear changes, and cranial nerve involvement. Genetic testing frequently finds a CHD7 mutation.
Probable CHARGE
Many key features are present, but not enough to meet the strict “definite” threshold. Day-to-day needs can still be similar, including feeding support, hearing or vision care, and airway monitoring. CHD7 changes may or may not be found.
Possible CHARGE
Some suggestive features occur without the full pattern. Families and clinicians keep watch as new information and growth clarify the picture over time. Genetic results can be negative or uncertain.
CHD7-positive
A disease-causing CHD7 variant is identified alongside typical clinical features. This supports diagnosis and helps guide anticipatory care and screening. Even within this group, intensity can range from mild to severe.
CHD7-negative
No CHD7 change is found despite clinical signs suggesting CHARGE. Care still follows CHARGE-informed plans, and re-evaluation may uncover other genes or clarify findings later. Not everyone will experience every type.
What genetics can tell you about symptoms
Certain CHD7 gene changes, the main genetic cause of CHARGE syndrome, disrupt early organ development, which can lead to coloboma (eye gaps), heart defects, atresia of the choanae (blocked nasal passages), growth delays, and hearing loss. Different variants can shift severity across these features.
Causes and risk factors
CHARGE syndrome is most often caused by a new change in the CHD7 gene that starts in the baby. It can sometimes be inherited from a parent who carries the same gene change. There are no known pregnancy, lifestyle, or environmental causes, and there are no proven ways to prevent it. Risk factors for CHARGE syndrome mainly include having a parent who carries a CHD7 change, and very rarely the change is present only in a parent’s egg or sperm cells. Genetic testing can sometimes clarify your personal risk.
Environmental and biological risk factors
Families often wonder what might raise the chance of CHARGE syndrome. Doctors often group risks into internal (biological) and external (environmental). Here’s what we know about environmental and biological risk factors for CHARGE syndrome, including where evidence is solid and where it’s still limited.
As a father's age increases, new changes in sperm cells at conception become slightly more likely. This can modestly raise the chance of conditions present from birth, including CHARGE syndrome.
No specific environmental exposures have been proven to increase risk. General pregnancy precautions still matter, such as avoiding high-dose radiation and toxic metals or solvents.
Genetic risk factors
CHARGE syndrome most often results from a change in a single gene called CHD7. Understanding the genetic causes of CHARGE syndrome can guide testing and family planning. Most cases arise as a new (de novo) change with no family history; a smaller number are inherited in an autosomal dominant way. People with the same risk factor can have very different experiences.
CHD7 gene changes: Most people with CHARGE syndrome have a change in the CHD7 gene. These changes can turn the gene off or alter how it works during early development. Genetic testing can identify many of these changes.
De novo variants: In many families, the CHD7 change is new in the child. Parents typically do not carry it in their blood, which explains a negative test. This lowers but does not remove the chance of it happening again.
Autosomal dominant pattern: When inherited, one altered copy of CHD7 is enough to cause CHARGE syndrome. An affected parent has a 50% chance of passing the change to each child. Features may be mild or more complex from one person to another.
Parental mosaicism: A parent can carry the CHD7 change in a small fraction of egg or sperm cells without it showing on routine tests. This rare situation can raise recurrence risk in future pregnancies. Specialized testing and counseling can help clarify options.
Rare other genes: Very rarely, changes in another gene, such as SEMA3E, have been linked to CHARGE-like features. Some people have small chromosome changes that include the CHD7 region. These uncommon causes are considered when CHD7 testing is negative.
Variable expressivity: The same CHD7 change can lead to different features and severity. This reflects how the change interacts with a person’s wider genetic background. Even within one family, outcomes can vary.
Family history clues: A parent with subtle features may carry a CHD7 change related to CHARGE syndrome. Careful family history and examination can reveal mild signs. This information guides testing and recurrence counseling.
No ancestry pattern: CHARGE syndrome occurs in all ethnic and racial groups. There is no known population with higher or lower inherited risk. Risk estimates rely on family findings rather than background.
Lifestyle risk factors
CHARGE syndrome is a congenital condition; lifestyle habits do not cause it, but daily routines can influence symptoms, growth, and complications. Thoughtful nutrition, movement, sleep, and sensory-aware routines can improve breathing, feeding safety, stamina, and participation. The points below focus on how lifestyle affects CHARGE syndrome in practical ways.
Texture-modified foods, slow pacing, and careful chewing can lower aspiration risk during meals. Upright posture and lingering upright after eating can reduce coughing and pneumonia risk.
Calorie- and protein-dense meals or supplements help support catch-up growth and postoperative healing. Dietitians can tailor plans to balance tube feeds and oral intake without worsening reflux.
Smaller, more frequent meals and avoiding reflux-triggering foods can lessen heartburn and vomiting. Better reflux control lowers aspiration risk and improves feeding comfort.
Adequate fluids and fiber help prevent constipation common in CHARGE. Softer stools reduce abdominal pressure that can worsen reflux and feeding intolerance.
Risk prevention
CHARGE syndrome is genetic and present from birth, so it can’t be prevented outright. Prevention here means lowering complications, protecting growth, and finding issues early so they can be treated. Prevention works best when combined with regular check-ups. For families, noticing early symptoms of CHARGE syndrome—like noisy breathing or feeding struggles—can speed referrals and support.
A single, shared care plan links cardiology, ENT, eye care, audiology, feeding, and therapy services. Regular reviews help catch problems early and reduce emergency visits.
Routine vaccines and flu/COVID shots lower risks from respiratory and ear infections. Good handwashing and staying away from sick contacts add extra protection for children with CHARGE syndrome.
Early assessment of the nose, throat, and windpipe helps prevent breathing crises. Having an emergency plan for colds or wheezing can reduce hospital visits.
Regular heart checks and timely surgery when needed prevent strain on the lungs and improve feeding and growth. Clear follow-up schedules help families plan care.
Transmission
CHARGE syndrome is not contagious; it cannot be caught through coughing, touch, or everyday contact. Most cases happen because of a new change in a gene called CHD7 that occurs for the first time in the child, so the parents typically do not carry it. When a parent has CHARGE syndrome, inheritance is autosomal dominant, meaning each pregnancy has a 50% chance to pass on the changed gene. Very rarely, a parent without features may carry the change in a small number of egg or sperm cells, which can slightly raise the chance of having another child with CHARGE syndrome. Genetic counseling and testing can explain how CHARGE syndrome is inherited and the genetic transmission of CHARGE syndrome in your family.
When to test your genes
Consider genetic testing if you or your child shows key CHARGE features (coloboma, choanal atresia, ear anomalies/hearing loss, heart defects, growth or genital differences), or if a clinician suspects CHARGE based on exam. Test early to guide care plans and screening. Parents planning future pregnancies may also consider testing.
Diagnosis
CHARGE syndrome is usually identified by a pattern of features present from birth, then confirmed with specific tests. Doctors look at vision, hearing, breathing, feeding, heart, and growth to see how the pattern fits. Getting a diagnosis is often a turning point toward answers and support. When features are subtle early on, the genetic diagnosis of CHARGE syndrome can help clarify the picture and guide care plans.
Clinicians look for a recognizable combination such as eye coloboma, heart differences, restricted back of the nose, genital and growth concerns, and characteristic ears. The overall pattern, not any single sign, points strongly toward CHARGE syndrome.
A blood or saliva test checks the CHD7 gene for a disease‑causing change. Finding a CHD7 variant confirms the diagnosis and can inform family counseling.
An ophthalmologist looks for coloboma and other eye differences that can affect vision. Documenting these features supports the clinical diagnosis and guides vision care.
Newborn hearing screening is followed by detailed hearing tests. Results help confirm ear involvement and shape hearing support, such as hearing aids or implants.
Stages of Charge syndrome
Charge syndrome does not have defined progression stages. It is present from birth, and features affect different body systems in their own ways over time, so it does not follow a predictable stage pattern. Different tests may be suggested to help confirm the diagnosis and check the heart, breathing, hearing, vision, feeding, and hormones. Doctors also consider early symptoms of Charge syndrome and family history, and genetic testing can confirm a suspected diagnosis and guide ongoing follow-up with the right specialists.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and the answer for Charge syndrome varies by the features present in each person. Survival has improved greatly with modern care. Most babies who receive timely treatment for breathing, feeding, and heart issues now survive infancy, and many reach adulthood. The outlook is not the same for everyone, but steady progress in surgery, hearing and vision support, and early therapies has led to better learning, mobility, and communication outcomes over time.
Prognosis refers to how a condition tends to change or stabilize over time. In Charge syndrome, early symptoms of Charge syndrome—such as airway narrowing, trouble swallowing, heart defects, and vision or hearing differences—shape the first months and years. Growth may be slower, and development can be delayed, yet many children make meaningful gains with coordinated care. Some people experience ongoing medical needs like feeding tube support or tracheostomy, while others notice these supports can be reduced as anatomy grows and strengthens.
Looking at the long-term picture can be helpful. Adult life with Charge syndrome is increasingly common; many adults live with partial hearing or vision, balance challenges, or hormone needs, but participate in school, work programs, and family life with tailored support. Mortality is highest in the first years when multiple critical anomalies overlap; beyond early childhood, life expectancy improves, especially when airway and heart issues are well managed. With ongoing care, many people maintain good quality of life, and independence ranges from supported to largely self-directed. Talk with your doctor about what your personal outlook might look like, including which health checks and therapies can make the biggest difference now and later.
Long-term effects
CHARGE syndrome can have lifelong effects that touch vision, hearing, breathing, growth, and development. Early features of CHARGE syndrome often include feeding and airway challenges, and these can shape long-term health into adolescence and adulthood. Long-term effects vary widely, and no two people share the exact same course. Many reach new milestones over time, though some needs remain ongoing.
Differences in eye structure can reduce sharpness, narrow side vision, or affect depth perception. Light sensitivity and glare may be ongoing.
Many have permanent hearing loss that can range from mild to profound. Ear shape or middle ear changes in CHARGE syndrome can add fluctuating hearing issues.
Narrow nasal passages or airway softness can make breathing noisy or effortful, especially during infections. Some continue to have sleep-disordered breathing.
Swallow coordination may remain difficult and increase the chance of food going the wrong way. Ongoing reflux can add throat discomfort or coughing after meals.
How is it to live with Charge syndrome?
Living with CHARGE syndrome often means coordinating many moving parts—hearing and vision differences, feeding or breathing support early on, and regular visits with specialists—while finding a daily rhythm that works for you. Many children and adults build strong routines with therapies for speech, mobility, and learning, using adaptive tools for communication and vision or hearing to stay engaged at home, school, and work. Families, caregivers, and classmates may need patience and clear communication as they learn how best to support energy levels, sensory needs, and medical appointments, but with planning and the right team, participation in everyday activities and community life is very possible. For many, progress is steady and meaningful, and celebrating small wins keeps motivation and connection strong.
Treatment and drugs
Treatment for CHARGE syndrome focuses on the specific needs of each person and often involves a team that may include ear, eye, heart, airway, feeding, and developmental specialists. Early care commonly includes surgery for heart or airway problems, procedures to help with feeding and growth, and hearing or vision supports such as hearing aids, cochlear implants, glasses, or vision therapy. Therapies like speech and language therapy, physical and occupational therapy, and educational support help with communication, mobility, and learning as children grow; supportive care can make a real difference in how you feel day to day. Medicines may be used for reflux, breathing symptoms, infections, or hormonal issues, and a doctor may adjust your dose to balance benefits and side effects. Ongoing follow-up through childhood and into adulthood is important, since needs can change over time and new issues can appear as people with CHARGE syndrome mature.
Non-drug treatment
Living with CHARGE syndrome often means coordinating care across hearing, vision, feeding, breathing, and balance needs. Non-drug treatments often lay the foundation for progress at every age, from infancy through school years and into adulthood. Early, team-based therapies can support development, communication, and independence. Acting on early symptoms of CHARGE syndrome—like feeding difficulty or delayed milestones—can speed referrals to the right specialists.
A lead clinician or nurse navigator helps organize appointments and share information across specialties. This reduces duplicated testing and keeps goals aligned for CHARGE syndrome care.
Home- and clinic-based supports in the first years focus on movement, feeding, vision, hearing, and communication. Starting early can improve long-term skills in CHARGE syndrome.
Exercises target strength, balance, and coordination affected by vestibular (inner ear) differences. Therapists adapt play and daily routines to build mobility safely.
Training builds fine-motor skills, self-care, and sensory processing. Therapists modify tools and environments to make dressing, writing, and play easier.
Your genes may have an impact on how drugs work for you
Medicines used in CHARGE syndrome can work differently because common gene changes affect how bodies absorb, activate, or clear drugs. Genetic testing and careful dosing help clinicians choose safer, more effective treatments, especially for heart rhythm drugs, anesthesia, and hearing-related therapies.
Pharmacological treatments
Medicines for CHARGE syndrome are chosen based on the specific symptoms affecting each person, rather than one drug for the condition itself. Because early symptoms of CHARGE syndrome often include feeding problems and heartburn-like discomfort, acid-reducing drugs are common in infancy and childhood. Not everyone responds to the same medication in the same way. Care plans usually change over time as needs shift from childhood into adulthood.
Proton pump inhibitors such as omeprazole or lansoprazole, and the H2-blocker famotidine, lower stomach acid to treat reflux and esophagitis. They may ease choking, irritability, or poor weight gain linked to reflux. Doctors sometimes adjust doses over time.
Osmotic laxatives like polyethylene glycol (PEG 3350) or lactulose soften stools and make bowel movements more regular. Regular bowel care can reduce feeding discomfort and abdominal pain.
Sex hormone therapy with low-dose testosterone for males or estrogen with later progesterone for females can trigger and support puberty when natural hormone signals are low. Treatment is introduced gradually and monitored with labs and growth checks.
Recombinant growth hormone (somatropin) may be used when testing confirms growth hormone deficiency. It can improve height velocity and support bone health, with regular monitoring for side effects.
Genetic influences
In most families, CHARGE syndrome happens because of a new change in a single gene rather than something passed down from a parent. The gene most often involved is called CHD7; a change in CHD7 disrupts early development of several organs and senses, and is the main genetic cause of CHARGE syndrome. When CHARGE syndrome is inherited, one altered copy is enough to cause the condition (autosomal dominant), so an affected parent has a chance to pass it on. Some parents with a child affected by CHARGE have no signs themselves; this is usually due to a brand-new gene change or, rarely, a parent carrying the change in only some cells (mosaicism), which makes the chance of it happening again low but not zero. Even with the same gene change, people can have very different symptoms and medical needs. Genetic testing for CHD7 can confirm the diagnosis in many people with CHARGE syndrome and helps guide family planning and care.
Is Charge syndrome genetic?
Genetics play a central role in CHARGE syndrome. Most cases are caused by changes in the CHD7 gene, usually new (not inherited) variants; a minority are inherited in an autosomal dominant pattern. Genetic testing confirms diagnosis and supports family planning.
Pharmacogenetics—how genetics influence drug effects
In Charge syndrome, the underlying CHD7 gene change guides care by showing which organs need the most protection, and that often influences which medicines are chosen and how they’re dosed. Genetic testing can sometimes identify how your body processes certain medicines, which helps the care team pick safer options or adjust the amount you take. While CHD7 itself isn’t known to speed up or slow down common drug‑processing enzymes, many living with it have heart, airway, kidney, vision, or hearing differences that make some drugs riskier than others. For example, kidney anomalies may call for lower doses or avoiding medicines that can strain the kidneys; ear differences make teams extra cautious with drugs that can harm hearing; and complex airways mean sedatives and anesthesia require specialist planning. Standard pharmacogenetic panels used in general care may still be useful on a case‑by‑case basis, combined with age, organ function, and the full care plan for Charge syndrome.
Interactions with other conditions
Colds, flu, or RSV can hit harder, because narrowed nasal passages, swallowing problems, and reflux raise the chance of choking or lung infections; heart defects can add strain during any respiratory illness. Doctors call it a “comorbidity” when two conditions occur together. Some people also have reduced immune defenses and middle‑ear differences, so ear infections may be frequent and lingering, which can further reduce hearing and slow speech progress. Vision and hearing differences may overlap with learning or attention disorders, making school supports and communication plans even more important. Endocrine issues like low sex hormones or growth hormone deficiency and kidney anomalies can change how other conditions are managed and how medicines are dosed; anesthesia for dental or surgical care can also be higher risk because of airway differences in CHARGE syndrome. When early symptoms of CHARGE syndrome overlap with problems like reflux, asthma, or recurrent ear infections, coordinated care helps teams avoid duplicate treatments and spot what is truly driving a flare.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies born with unusual combinations of eye, ear, heart, and breathing problems, often without a single name to link them. Families and midwives noticed that one child might have a cleft lip and trouble feeding, while a cousin had severe hearing loss and balance issues. In everyday life, this looked like a newborn who needed help to breathe right after delivery, or a toddler who fell often and seemed sensitive to light. These early accounts captured the day-to-day reality long before anyone knew these features could be part of one condition.
First described in the medical literature as a cluster of key findings in the 1970s and 1980s, the pattern was later organized under the acronym CHARGE. The letters reflected common features seen together: eye coloboma, heart differences, blockage in the nasal passages, slowed growth, genital and urinary differences, and ear anomalies with hearing loss. Initially understood only through symptoms, later studies made it clear that CHARGE was not just a checklist but a spectrum, with some people having many features and others just a few.
From early theories to modern research, the story of CHARGE syndrome shows how careful observation led to clearer definitions. As medical science evolved, doctors recognized that certain combinations—like eye coloboma with characteristic outer ear shape and balance problems—strongly suggested CHARGE. Over time, descriptions became more inclusive of subtler signs, such as feeding difficulties, developmental delays, and distinctive inner ear changes seen on imaging. This shift helped more children and adults receive an accurate diagnosis, even when not every “letter” of the acronym was present.
Advances in genetics reshaped the understanding of CHARGE syndrome in the 2000s, when changes in the CHD7 gene were identified in many affected individuals. This gene acts like a regulator that fine-tunes how other genes turn on and off during early development, which helps explain why CHARGE can affect many organs at once. Genetic testing brought clarity for families, confirmed diagnoses in borderline cases, and guided care by highlighting risks that might otherwise be missed, such as heart or airway differences.
Despite evolving definitions, the core goal has stayed the same: to recognize CHARGE syndrome early and coordinate care. Knowing the condition’s history helps explain why some adults were given different labels in childhood, and why modern criteria emphasize both visible features and inner structures like the semicircular canals in the inner ear. Today, the history of CHARGE continues to influence practice—reminding clinicians to look beyond any single symptom and prompting families to seek multidisciplinary support from birth through adulthood.